ScholarLens Back to search
2010•China Medical HeraldRequires access

Comparative study of Fluoxetine and Amitriptyline in the treatment of depression

Shi Hongju

Open publisher page 0 citations

Abstract

Objective: To determine the efficacy and safety for Fluoxetine and Amitriptyline in the treatment of depression. Methods: 60 patients were randomly assigned to receive Fluoxetine (n=30) and Amitriptyline (n=30) for 6 weeks. The efficacy were assessed by Hamilton Deprssion Rating Scale (HAMD), Clinical Global Impression (GCI) and the side effects were assessed by Treatmennt Emergent Sympots Scale (TESS). Results: Before and after treatment, the HAMD, CGI-SI score of Fluoxetine group and Amitriptyline group were compared, the differences were not statistically significant (P0.05). The inci dence of adverse reactions of Fluoxetine group was significantly lower than the Amitriptyline group (P0.01). Conclusion: The efficacy of Fluoxetine and Amitriptyline in the treatment of depression were nearly equal, but Fluoxetine has less side effects.

About this research paper

What this paper is about

Objective: To determine the efficacy and safety for Fluoxetine and Amitriptyline in the treatment of depression. Methods: 60 patients were randomly assigned to receive Fluoxetine (n=30) and Amitriptyline (n=30) for 6 weeks. The efficacy were assessed by Hamilton Deprssion Rating Scale (HAMD), Clinical Global Impression (GCI) and the side effects were assessed by Treatmennt Emergent Sympots Scale (TESS). Results: Before and after treatment, the HAMD, CGI-SI score of Fluoxetine group and Amitriptyline group were compared, the differences were not statistically significant (P0.05). The inci dence of adverse reactions of Fluoxetine group was significantly lower than the Amitriptyline group (P0.01). Conclusion: The efficacy of Fluoxetine and Amitriptyline in the treatment of depression were nearly equal, but Fluoxetine has less side effects.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To determine the efficacy and safety for Fluoxetine and Amitriptyline in the treatment of depression. Methods: 60 patients were randomly assigned to receive Fluoxetine (n=30) and Amitriptyline (n=30) for 6 weeks. The efficacy were assessed by Hamilton Deprssion Rating Scale (HAMD), Clinical Global Impression (GCI) and the side effects were assessed by Treatmennt Emergent Sympots Scale (TESS). Results: Before and after treatment, the HAMD, CGI-SI score of Fluoxetine group and Amitriptyline group were compared, the differences were not statistically significant (P0.05). The inci dence of adverse reactions of Fluoxetine group was significantly lower than the Amitriptyline group (P0.01). Conclusion: The efficacy of Fluoxetine and Amitriptyline in the treatment of depression were nearly equal, but Fluoxetine has less side effects.

Key concepts: Amitriptyline, Fluoxetine, Hamd, Medicine, Clinical Global Impression, Depression (economics), Clinical efficacy, Rating scale

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Comparative study of Fluoxetine and Amitriptyline in the treatment of depression — Research Paper | ScholarLens